Doxorubicin pathways: pharmacodynamics and adverse effects.

Article Details

Citation

Copy to clipboard

Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB

Doxorubicin pathways: pharmacodynamics and adverse effects.

Pharmacogenet Genomics. 2011 Jul;21(7):440-6. doi: 10.1097/FPC.0b013e32833ffb56.

PubMed ID

21048526 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Doxorubicin